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OBJECTIVES: This study examined periarticular multimodal drug injection and the use of nonsteroidal anti-
inflammatory drugs for an early analgesic effect after total knee arthroplasty and total hip arthroplasty. Patient
satisfaction and benefits from the treatment were also assessed.
METHODS: A total of 110 patients who were scheduled to undergo total knee arthroplasty and 86 patients who
were scheduled to undergo total hip arthroplasty were divided into two groups, the study group and the
control group. The study group received a periarticular multimodal drug injection during surgery. The control
group received an equal volume of normal saline. All patients received an analgesia pump and a moderate dose
of nonsteroidal anti-inflammatory drugs. Resting and motion Numeric Rating Scale scores, the Western Ontario
and McMaster Universities Arthritis Index, knee or hip joint range of motion, length of postoperative hospital
stay, patient satisfaction, total nonsteroidal anti-inflammatory drug consumption and side effects were
recorded.
RESULTS: Both study groups exhibited significant improvement in pain Numeric Rating Scale scores during rest
and exercise several days after the surgery. The range of joint motion was greater in the study group, and the
length of postoperative hospital stay was shorter than that in the control group. Patients in the study group
consumed fewer nonsteroidal anti-inflammatory drugs and reported greater satisfaction with surgery.
CONCLUSION: Intraoperative periarticular multimodal drug injection significantly relieved pain after surgery
and reduced nonsteroidal anti-inflammatory drug consumption. These patient had a better postoperative
experience, including satisfaction and rehabilitation.
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’ INTRODUCTION
Total knee arthroplasty (TKA) and total hip arthroplasty
(THA) are important treatments for severe joint disease that
can relieve joint pain and improve joint function. Approxi-
mately 90% of patients with pain and dysfunction show
improvement after TKA, which also improves their quality of
life. Most patients (85%) are very satisfied with the curative
effect of surgery and postoperative quality of life (1,2). How-
ever, postoperative pain has a harmful effect on important
organs and directly affects postoperative rehabilitation exer-
cises (3,4). Pain after surgery increases patients’ concerns
about rehabilitation exercises, which affects the rehabilitation
process. Moreover, the clinical application of many analgesic
methods is limited (5-7). Therefore, identification of effective
and safe analgesic treatments is an important challenge. Peri-
articular injection effectively prevents pain and leads to a
lower systemic side effect profile. This randomized, single-
blind study aimed to compare the analgesic effects of periar-
ticular injection in TKA and THA postoperative patients and
nonsteroidal anti-inflammatory drug (NSAID) use.
’ MATERIALS AND METHODS
Patient population
Approval was obtained from the Biomedical Ethics group
of the medical department of Xi’an Jiaotong University
(number 2012-693). From 2012.9.1 - 2015.11.01, we conducted
a prospective, randomized single-blinded study of all eligible
men and nonpregnant womenwhowere scheduled to undergo
primary TKA and THA for osteoarthritis. All patients were
at least 20 years old and no more than 80 years old. The
following inclusion criteria were used: (1) the American
Society of Anesthesiologists (ASA) grade I - III rating; (2)DOI: 10.6061/clinics/2017(12)03
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weight index of 20 - 35 kg/m2; (3) unilateral TKA and THA;
(4) ability to cooperate with the investigation and under-
stand the pain score; and (5) provision of informed consent.
The following exclusion criteria were applied: (1) did not
meet the above requirements; (2) nervous or mental dis-
orders; (3) known drug allergy or tolerance to study drugs;
(4) renal insufficiency or abnormal liver enzymes; (5) acute or
chronic knee infection; and (6) serious cardiovascular disease,
diabetes, or uncontrolled angina. All patients were randomly
divided into two groups. No significant differences in base-
line demographics were observed between the two groups
(Table 1). Figure 1 shows a detailed flowchart describing our
selection criteria and decision-making process in determining
study participants.
Patient grouping
A biostatistician who was blinded to the research study
generated a random number sequence with a simple random
number table. All random number cards were settled in sea-
led envelopes. Patients were allocated either to the study
group or control group based on whether the random num-
ber was odd or even when he or she was enrolled. Injections
in the study group consisted of 200 mg of ropivacaine, 30 mg
of ketorolac, 5 mg of hexadecadrol, and 0.3 ml of epine-
phrine. These drugs were mixed in a sterile normal saline solu-
tion with a combined volume of 50 ml. The control group
received an equal volume of normal saline solution.
All patients received general anesthesia, and the same
surgeon performed all surgeries. All patient implants are
from Johnson & Johnson of America. The mixed drugs were
injected in the entire length of the wound, especially in the
subcapsular muscles and subcuticular tissues. All patients
received patient-controlled analgesia (2 mg/kg sufentanil and
0.2 mg/kg tropisetron mixed with sterile normal saline
solution in a total volume of 100 ml), and we limited the drip
rate to 2 ml/h. Patients were administered moderate NSAIDs
(celecoxib) based on their needs 6 h postoperatively.
All patients were asked to perform ankle pump exercises
during the 24 h after surgery and active flexion movement
24 h after surgery. Pain scores, Western Ontario and McMaster
Universities Arthritis Index (WOMAC) scores, adverse reac-
tions, range of motion and use of NSAIDs were recorded daily.
The average of the measurements was calculated. Patient
satisfaction was assessed on the seventh day after surgery.
Observation indexes
Pain scores were measured using the Numeric Rating Scale
score (NRS), where 0 indicated no pain and 10 indicated the
worst imaginable pain. We recorded the pain score, range
of motion, and NSAID use 12 h, 24 h, 48 h, 72 h, 4 d, 5 d, 6 d,
7 d, and 14 d after surgery. The number of reports of nausea,
vomiting and other adverse reactions was recorded during
hospitalization. Evaluations of satisfaction, including pain
control, hospitalization days, functional recovery and general
satisfaction, were recorded on the seventh day after surgery.
Statistical analysis
Statistical interactions between the two groups and time
were assessed to determine the longitudinal effects of group
on the outcome of interest. Enumeration data were evalua-
ted using the chi-square test, and measurement data were
analyzed using t tests. Our sample size estimate was based
Table 1 - Demographic data for patients in the study.
TKA study group
(n=55)
TKA control group
(n=55)
THA study group
(n=43)
THA control group
(n=43)
Age 63±11 65±9 58±11 55±13
Sex (male: female) 13:42 15:40 19:24 18:25
BMI 24.16±2.69 24.09±3.11 23.35±2.23 22.90±3.56
HSS score 49.45±12.96 49.02±14.23
Harris score 46.87±13.29 43.42±15.27
WOMAC score 49.10±13.18 50.63±14.02 41.30±12.73 38.51±14.92
All data except sex are denoted as the mean±SD. There was no significant difference between the two groups.
WOMAC score: Western Ontario and McMaster Universities Arthritis Index.
Figure 1 - Subject inclusion decision tree.
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on the WOMAC score. According to the results of our pre-
experiment (n=10), we defined an important between-group
difference to be approximately 2 points in the TKA group
and 3 point in THA group 2 to 4 days post-arthroplasty.
The power was set at 0.80 and the overall type I error
probability at 0.05. Applying these assumptions yielded an
approximate required sample size of 41 subjects in the TKA
groups and 36 subjects in the THA groups. Because many of
the late eligible patients volunteered to join, we expanded
the sample size.
All information was processed using SPSS 23.0. Statistical
significance was set at po0.05.
’ RESULTS
We found that NRS scores with activity within a few days
after surgery were lower in the study group than in the
control group (Table 2, Figure 2). Patients in the THA study
group also reported less pain than those in the TKA study
group.
The NRS scores at rest also displayed the same trend
(Table 3, Figure 3).
The TKA study group showed a larger range of knee
flexion within 4 days postoperatively than the control group,
whereas the THA study group showed a larger range of hip
flexion within 7 days postoperatively (Table 4, Figure 4).
These differences were significant (po0.05).
The study group was administered a dose of celecoxib that
was far lower than that in the control group. The TKA study
group received a total of 965 mg of Celebrex, while the con-
trol group received 1,325 mg in one week (po0.05). The THA
study group was treated with 918 mg of Celebrex, while
the control group was treated with 1,238 mg in one week
(po0.05) (Table 5, Figure 5).
The WOMAC scores of the TKA study group were signi-
ficantly better than those of the control group at 48 h, 72 h,
and 4 d, and the scores of the THA study group were better
than those of the control group at 48 h, 72 h, 4 d and 5 d
(Table 6, Figure 6). These differences were significant (po0.05).
The length of postoperative hospital stay was significantly
different between groups. The hospital stay duration in the
TKA study group was 9.25±1.99 days, compared to 10.44±
2.62 days in the control group (po0.05), whereas the hospital
stay duration in the THA study group was 8.08±2.11 days,
compared to 10.06±2.59 days in the control group (po0.05).
We found that postoperative pain satisfaction was sig-
nificantly higher in both study groups than in the control
group. We also observed that functional recovery and gen-
eral satisfaction in the THA study group were significantly
higher than in the control group (po0.05). However, no
Table 2 - The NRS scores with activity.
TKA study group TKA control group t-value p-value THA study group THA control group t-value p-value
12 h 6.83±0.78 7.25±0.80 -2.832 0.006 6.77±0.88 7.77±0.90 -5.185 o0.001
24 h 6.29±0.73 6.69±0.88 -2.567 0.012 6.13±0.82 6.96±1.14 -3.894 o0.001
48 h 5.68±0.72 6.05±0.82 -2.483 0.015 5.42±0.79 6.25±1.13 -2.980 0.004
72 h 5.11±0.75 5.43±0.77 -2.191 0.031 4.77±0.78 5.42±1.21 -2.071 0.041
4 d 4.43±0.65 4.54±0.82 -0.757 0.451 4.07±0.80 4.68±1.13 -2.182 0.032
5 d 3.85±0.60 3.96±0.79 -0.839 0.403 3.61±0.72 3.90±1.03 -1.495 0.139
6 d 3.31±0.60 4.47±0.74 -1.219 0.225 2.89±0.66 3.25±0.93 -2.067 0.042
7 d 2.82±0.60 2.96±0.76 -1.092 0.277 2.40±0.65 2.72±0.90 -1.933 0.057
14 d 1.86±0.41 1.84±0.36 0.245 0.807 1.26±0.57 1.33±0.65 .0.562 0.576
Figure 2 - The NRS scores with activity. *The average NRS score with activity in the TKA study group was lower than that in the control
group at 12 h, 24 h, 48 h, and 72 h; the average NRS score in the THA group was lower than that in the control group at 12 h, 24 h, 48 h,
72 h, 4 d and 6 d.
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significant differences in the degree of satisfaction related to
hospitalization days were observed.
’ DISCUSSION
Adequate postoperative pain control in total joint replace-
ment (TJR) during postoperative functional recovery is very
important, and a sufficient analgesic effect can help relieve
pain, allow patients to get out of bed earlier to exercise,
restore joint function, and prevent the formation of deep vein
thrombosis (DVT) (8). Severe pain also leads to prolonged
hospital stays and increased opioid use. Many treatment
options for joint replacement postoperative analgesia exist,
but all these options have limitations. For instance, epidural
analgesia frequently causes complications, such as nausea,
hypotension, and urinary retention. TJR patients often
receive anticoagulant drugs to prevent DVT, but these agents
increase the risk of operative bleeding (9,10). The effect of
intravenous analgesia is poor, and patients are prone to respi-
ratory depression, nausea, vomiting, itching, and sleepiness
(10,11). We compared resting and motion NRS scores, joint
range of motion, WOMAC scores, time of active exercise,
length of postoperative hospital stay, patient satisfaction, total
NSAID consumption and side effects between the two groups
to identify safer and more effective perioperative analgesic
methods. Our results demonstrated that periarticular injection
for postoperative pain control led to good patient recovery
and effectively reduced the use of NSAIDs, which can cause
Table 3 - The NRS scores at rest.
TKA study group TKA control group t-value p-value THA study group THA control group t-value p-value
12 h 5.10±0.89 5.58±0.94 -2.788 0.006 4.88±1.13 6.14±1.01 -5.444 o0.001
24 h 4.44±0.84 5.00±0.88 -3.423 0.001 4.29±0.93 5.24±1.10 -4.301 o0.001
48 h 3.88±0.63 4.28±0.75 -3.018 0.003 3.50±1.01 4.41±1.22 -3.750 o0.001
72 h 3.48±0.58 3.72±0.71 -1.965 0.052 3.03±0.79 3.65±1.12 -2.996 0.004
4 d 3.05±0.54 3.26±0.60 -1.893 0.061 2.37±0.67 2.94±0.96 -3.247 0.002
5 d 2.51±0.49 2.67±0.50 -1.747 0.084 1.90±0.66 2.26±0.83 -2.213 0.030
6 d 2.12±0.46 2.23±0.46 -1.240 0.218 1.48±0.59 1.72±0.74 -1.674 0.098
7 d 1.80±0.43 1.86±0.41 -0.797 0.427 1.14±0.56 1.30±0.63 -1.227 0.223
14 d 1.24±0.23 1.21±0.22 0.549 0.584 0.79±0.33 0.86±0.42 -0.910 0.366
Figure 3 - *The NRS scores at rest. The average score in the TKA study group was lower than that in the control group at 12 h, 24 h, and
48 h, whereas the average score in the THA study group was lower than that in the control group at 12 h, 24 h, 48 h, 72 h, 4 d and 5 d.
Table 4 - Range of motion after the operation.
TKA study group (˚) TKA control group (˚) t-value p-value THA study group (˚) THA control group (˚) t-value p-value
12 h 15.33±3.92 13.04±3.70 3.253 0.002 19.06±5.16 15.55±4.67 3.306 0.001
24 h 22.18±5.59 17.85±5.13 4.231 o0.001 31.08±8.12 23.54±5.72 4.954 o0.001
48 h 33.05±7.17 28.22±7.34 3.497 0.001 50.69±9.27 35.71±6.49 8.644 o0.001
72 h 45.16±7.87 40.05±9.64 3.045 0.003 62.23±9.62 43.84±7.29 9.957 o0.001
4 d 56.91±8.42 52.64±10.74 2.321 0.022 70.56±9.84 57.66±8.23 6.582 o0.001
5 d 68.82±9.26 65.76±10.14 1.650 0.102 80.66±12.96 61.54±9.20 7.858 o0.001
6 d 78.80±7.94 76.91±9.64 1.123 0.264 84.48±12.58 68.64±8.90 6.716 o0.001
7 d 86.00±7.72 86.53±8.70 0.336 0.737 88.01±12.68 74.52±9.47 5.570 o0.001
14 d 100.15±10.51 100.84±10.56 0.344 0.732 91.79±11.96 87.45±10.59 1.780 0.079
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serious side effects. The limitations of our study include the
short-term follow-up period and that patients may not have
effectively evaluated their situation and NSAID drug use.
Our study found that NRS scores with activity or rest were
lower in the study group than in the control group during
the early perioperative period, and previous studies have
reported similar findings (11-15). Busch et al. (11) found
that the combination of ropivacaine and ketorolac trometha-
mine as a periarticular multimodal drug injection effectively
reduced the intake of opioids, and postoperative NRS scores
at 6 h, 12 h, and 24 h were significantly lower than those in
the control group during the perioperative period of TKA.
Figure 4 - Range of motion.
Table 5 - NSAID consumption.
TKA study group TKA control group t-value p-value THA study group THA control group t-value p-value
24 h 283.64±83.36 330.91±85.79 -2.931 0.004 265.91±77.59 307.14±83.79 -2.369 0.020
48 h 229.09±68.51 283.64±78.80 -3.874 o0.001 206.82±92.50 257.14±76.93 -2.736 0.008
72 h 185.45±55.84 212.73±47.35 -2.763 0.007 161.36±57.93 204.76±43.91 -3.901 o0.001
4 d 109.09±84.49 183.64±60.14 -5.331 o0.001 111.36±81.32 176.19±57.63 -4.247 o0.001
5 d 61.82±80.49 145.45±78.92 -5.502 o0.001 63.64±80.96 126.19±85.71 -3.481 0.001
6 d 60.00±78.41 89.09±83.16 -1.888 0.062 59.09±75.69 85.71±84.31 -1.542 0.127
7 d 36.36±64.88 58.18±73.76 -1.647 0.102 34.09±47.95 71.43±63.58 -3.084 0.003
Figure 5 - NSAID consumption.
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Wei Liu et al. (12) found that the average NRS score of
THA study patients was significantly lower than that in
the control group. Todd et al. (13) performed a randomized
double-blind controlled study and found that the combina-
tion of ropivacaine, adrenaline and ketorolac tromethamine
exhibited a better effect than the use of ropivacaine and
epinephrine alone, and it effectively reduced the amount of
morphine for analgesia (16). Dexamethasone as a long-term
glucocorticoid exhibits strong anti-inflammatory effects, and
ropivacaine or bupivacaine combined with dexamethasone
prolongs the effect of local anesthetics (17). Therefore, different
drugs and drug delivery methods exhibit different effects,
and these differences require further research. In addition,
on postoperative days 2 to 3, the experimental group showed
a better analgesic effect, and this difference gradually disap-
peared after 3 days. Although there was still a statistically
significant difference between the two groups, the difference
is very subtle and soon disappeared. This is because the per-
iarticular multimodal drug injection effect is relatively short.
We also noted that the effect of TKA postoperative analgesia
between the two groups is subtle, which indicates that intra-
operative periarticular multimodal drug injection may not be
sufficient to completely control postoperative pain in TKA
patients. All patients reported mild pain after 1 week.
Patients with better pain relief exhibited improved post-
operative motion and WOMAC scores. This study demon-
strated that the range of keen flexion of the TKA study group
patients within 4 days and that of the THA study group
patients within 6 days after surgery were better than that
in the control group. Early postoperative exercise is bene-
ficial for postoperative rehabilitation and may prevent some
treatment complications (18-22). In fact, similar to the VAS
score trend, this difference is not obvious in TKA. In parti-
cular, the difference in WOMAC scores between the two
groups is subtle because the WOMAC score is divided into
three parts; pain is only one part of it, and there were no
significant differences between the two groups in many
items of the WOMAC score.
We focused on the use of NSAIDs after surgery. Celecoxib
capsules are a relatively new selective COX-2 inhibitor that
primarily inhibit a COX-2 zymoprotein to block the synthesis
of prostaglandins and achieve anti-inflammatory effects.
Numerous studies have demonstrated that patients who
receive celecoxib exhibit a reduced incidence of nausea and
vomiting (28%). However, no research has used large sam-
ples to assess the side effects of celecoxib (23). Indeed, the
side effects of postoperative celecoxib analgesia remain a
problem that is difficult to ignore (23,24). Our results
demonstrated that the study group ingested much less cele-
coxib than the control group. Six patients in our study repor-
ted nausea and vomiting in the TKA study group compared
to 7 patients in the TKA control group, while 8 patients in the
THA group reported side effects. No cardiac or central ner-
vous system toxicity was observed. No significant differ-
ences were observed between the two groups, although the
long-term side effects of drug treatment require further
study. Indeed, previous studies have suggested that the long-
term use of NSAIDs significantly increases the incidence of
Table 6 - WOMAC scores after the operation.
TKA study group TKA control group t-value p-value THA study group THA control group t-value p-value
24 h 82.88±1.39 83.29±1.48 -1.497 0.137 82.14±0.93 81.88±2.80 0.572 0.569
48 h 75.68±2.22 79.14±1.79 -8.997 o0.001 78.18±1.94 80.02±4.29 -2.586 0.011
72 h 72.05±3.01 73.69±3.04 -2.834 0.005 72.39±3.58 75.62±5.54 -3.228 0.002
4 d 66.69±4.29 68.48±4.73 -2.075 0.040 64.91±5.97 69.79±6.06 -3.757 o0.001
5 d 61.71±6.42 63.60±5.31 -1.683 0.095 60.18±7.03 65.21±7.18 -3.285 0.001
6 d 57.23±6.02 57.44±5.60 -0.187 0.852 57.48±5.85 59.69±7.46 -1.535 0.128
7 d 52.76±5.44 53.88±6.07 -1.018 0.311 52.68±6.63 53.12±5.40 -0.334 0.739
14 d 47.66±5.78 46.18±6.95 -1.214 0.228 41.34±6.17 40.86±7.80 0.334 0.739
Figure 6 - WOMAC scores after the operation.
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adverse reactions (25). Our results showed that periarticular
multimodal drug injection significantly reduced the intake
of NSAIDs, which may reduce the discomfort caused by
NSAIDs. In this study, we recommended that patients take
no more than 200 mg daily, unless there is a special need.
Therefore, the difference between the two groups was not
very large but was sufficient to show that periarticular multi-
modal drug injection can effectively reduce the intake of
NSAIDs. With the development of new technologies, the use
of NSAIDs has shown a decreasing trend, but many drug
guides still recommend oral NSAIDs, which is why we selec-
ted NSAIDs to study. The ultimate goal is elimination of
NSAID for pain control in the future
We applied a digital classification method for the patients
to evaluate all aspects of satisfaction during hospitalization.
We found that postoperative pain satisfaction in the study
group was significantly higher than that in the control group,
and we also found that functional recovery and general
satisfaction in the THA study group were significantly higher
than in the control group. However, no significant differences
existed in the degree of satisfaction with the number of hospi-
talization days.
THA patients showed better pain control and rehabilita-
tion satisfaction than TKA patients. This result may be
because TKA patients feel more pain after surgery than THA
patients; thus, periarticular injection may be effective in con-
trolling postoperative pain in THA patients but may not be
sufficient to completely control postoperative pain in TKA
patients. Additionally, this difference between groups may
also be related to operation time, bleeding volume, degree of
tissue damage, patient expectations, and other relevant issues,
although these factors were not analyzed in the current study.
Our results suggest that we cannot focus only on pain control
after surgery in TJR patients; instead, a variety of measures
should be used to improve the prognosis of patients and their
comprehensive quality of life.
Periarticular multimodal drug injection is a simple, safe
surgery that effectively reduced the pain of patients after
TKA and THA, and this method effectively advanced the time
that patients began joint exercises, improved joint function
recovery, and shortened hospital stay. Local dosing in the joint
reduced the intake of NSAIDs, which may reduce NSAID-
induced damage to the digestive tract and kidney. We believe
that with the development of new technologies, the use NSAID
for pain control after TKA and THA will decrease.
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